Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Sales | 0 | 0 | 0 | 63 | 0 |
| Gross Profit | N/A | N/A | N/A | 63 | N/A |
| Operating Expenses | 29,394 | 22,065 | 31,796 | 30,914 | 0 |
| Operating Income | -29,394 | -22,065 | -31,796 | -30,851 | N/A |
| Other Income | 2,627 | 1,228 | 8,004 | 5,606 | 0 |
| Pre-tax Income | -26,767 | -20,837 | -23,792 | -25,244 | 0 |
| Net Income Continuous | -26,767 | -20,837 | -23,792 | -25,244 | N/A |
| Net Income | $-26,767 | $-20,837 | $-23,792 | $-25,244 | $N/A |
| EPS Basic Total Ops | -0.37 | -0.33 | -0.38 | -0.58 | N/A |
| EPS Basic Continuous Ops | -0.37 | -0.32 | -0.38 | -0.58 | N/A |
| EPS Diluted Total Ops | -0.37 | -0.33 | -0.38 | -0.58 | N/A |
| EPS Diluted Continuous Ops | -0.37 | -0.32 | -0.38 | -0.58 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.37 | -0.33 | -0.38 | -0.58 | N/A |
| EBITDA(a) | $-29,122 | $-21,881 | $-31,626 | $-30,675 | $N/A |